Search Count: 32
 |
Human Cdk8/Cyclin-C Complex With Inhibitor 2-9
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.57 Å Release Date: 2025-01-22 Classification: TRANSCRIPTION Ligands: EDO, GOL, A1IS8, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: EDO, GOL, A1IS8, DMS
 |
Human Cdk8/Cyclin-C Complex With Inhibitor 3-7
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2025-01-22 Classification: TRANSCRIPTION Ligands: CL, EDO, GOL, A1ITF, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: CL, EDO, GOL, A1ITF, DMS
 |
C-Terminal Bromodomain Of Human Brd2 With 5-(1-Benzyl-4-Chloro-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, PE4, A1IBV |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-06-26
Ligands: EDO, PE4, A1IBV
 |
N-Terminal Bromodomain Of Human Brd4 With (5-(4-Chloro-1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, A1IB5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-06-26
Ligands: EDO, A1IB5
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxo-1-(Tetrahydro-2H-Pyran-4-Yl)Ethyl)-6-Oxo-N-(2-Phenyl-2-(Pyridin-2-Yl)Ethyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2021-10-13 Classification: NUCLEAR PROTEIN Ligands: 80Z, EDO, PE4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-13
Ligands: 80Z, EDO, PE4
 |
Human Bcl6 Btb-Domain In Complex With Gsk137
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.04 Å Release Date: 2021-07-28 Classification: TRANSCRIPTION Ligands: TEQ, GOL, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: TEQ, GOL, DMS
 |
C-Terminal Bromodomain Of Human Brd2 With N-Methyl-4-Propionyl-1H-Pyrrole-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, V9B |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: EDO, PE4, V9B
 |
C-Terminal Bromodomain Of Human Brd2 With N5-Hydroxycyclohexyl-N3-Methyl-1-Phenylethyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9H, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: V9H, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With N4-Hydroxycyclohexyl-N2-Methyl-5-Phenylethyl-Furan-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9K, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: V9K, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With 1-Benzyl-N5-Cyclopropyl-N3-Methyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, VE5, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: EDO, VE5, PEG
 |
C-Terminal Bromodomain Of Human Brd2 With 6-Benzyl-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: UL5, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: UL5, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With (R)-N5-Cyclopropyl-N3-Methyl-2-Oxo-1-(1-Phenylethyl)-1,2-Dihydropyridine-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.28 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, ULH
 |
C-Terminal Bromodomain Of Human Brd2 With Oxabicyclo(Hexan-6-Yl)-N2-Methyl-6-((S)-1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, ULN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, PE4, ULN
 |
C-Terminal Bromodomain Of Human Brd2 With 6-((S)-Hydroxy(Phenyl)Methyl)-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, ULK
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-N4-Cyclopropyl-N2-Methyl-6-(1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: ULE, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: ULE, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With N4-((1R,5S,6R)-3-Oxabicyclo[3.1.0]Hexan-6-Yl)-6-((S)-Methoxy(Phenyl)Methyl)-N2-Methylpyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULQ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, ULQ
 |
C-Terminal Bromodomain Of Human Brd4 N-(2,2-Diphenylethyl)-4-Methoxy-3,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.51 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: V9Z |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: V9Z
 |
C-Terminal Bromodomain Of Human Brd2 With 5-(1-(1,3-Dimethoxypropan-2-Yl)-5-Morpholino-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, NV2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, PE4, NV2
 |
C-Terminal Bromodomain Of Human Brd2 With N-(2,2-Diphenylethyl)-1,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)-6-Oxo-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: VBH, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: VBH, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)-6-Oxo-N-(2-Phenylpropyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, VBE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, PE4, VBE